NO20065697L - Piperazinderivater av alkyloksindoler. - Google Patents

Piperazinderivater av alkyloksindoler.

Info

Publication number
NO20065697L
NO20065697L NO20065697A NO20065697A NO20065697L NO 20065697 L NO20065697 L NO 20065697L NO 20065697 A NO20065697 A NO 20065697A NO 20065697 A NO20065697 A NO 20065697A NO 20065697 L NO20065697 L NO 20065697L
Authority
NO
Norway
Prior art keywords
alkyloxindoles
piperazine derivatives
derivatives
new
prevention
Prior art date
Application number
NO20065697A
Other languages
English (en)
Inventor
Jozsef Barkoczy
Tibor Mezei
Gyula Simig
Balazs Volk
Dezsofi Rita Kapillerne
Original Assignee
Egis Gyogyszergyar Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0400954A external-priority patent/HU0400954D0/hu
Priority claimed from HU0500461A external-priority patent/HUP0500461A3/hu
Application filed by Egis Gyogyszergyar Nyrt filed Critical Egis Gyogyszergyar Nyrt
Publication of NO20065697L publication Critical patent/NO20065697L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Det tilveiebringes nye indol-2-onderivater med den generelle Formel (I). De nye forbindelsene er nyttige for behandling eller prevensjon av forstyrrelser i sentralnervesystemet eller det kardiovaskulære system.
NO20065697A 2004-05-11 2006-12-11 Piperazinderivater av alkyloksindoler. NO20065697L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0400954A HU0400954D0 (en) 2004-05-11 2004-05-11 Piperazine derivatives of alkyl oxindoles
HU0500461A HUP0500461A3 (en) 2005-05-05 2005-05-05 Pyperazine derivatives of alkyl-oxindoles
PCT/HU2005/000048 WO2005108363A1 (en) 2004-05-11 2005-05-10 Piperazine derivatives of alkyl oxindoles

Publications (1)

Publication Number Publication Date
NO20065697L true NO20065697L (no) 2007-02-02

Family

ID=89985994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065697A NO20065697L (no) 2004-05-11 2006-12-11 Piperazinderivater av alkyloksindoler.

Country Status (24)

Country Link
US (1) US20070219209A1 (no)
EP (1) EP1751106B1 (no)
JP (1) JP2007537226A (no)
KR (1) KR20070011551A (no)
AT (1) ATE412634T1 (no)
AU (1) AU2005240842B2 (no)
BG (1) BG109768A (no)
CA (1) CA2564009A1 (no)
CZ (1) CZ2006778A3 (no)
DE (1) DE602005010694D1 (no)
DK (1) DK1751106T3 (no)
EA (1) EA011280B1 (no)
ES (1) ES2317241T3 (no)
HR (2) HRP20060401A2 (no)
IL (1) IL178759A0 (no)
MX (1) MXPA06013064A (no)
NO (1) NO20065697L (no)
NZ (1) NZ551542A (no)
PL (1) PL1751106T3 (no)
PT (1) PT1751106E (no)
RS (1) RS20060620A (no)
SI (1) SI1751106T1 (no)
SK (1) SK51112006A3 (no)
WO (1) WO2005108363A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007537229A (ja) * 2004-05-11 2007-12-20 エギシュ ヂョヂセルヂャール エンニュ・エル・テー ジアルキルオキシインドールの新規なピペラジン誘導体
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes

Also Published As

Publication number Publication date
ES2317241T3 (es) 2009-04-16
PT1751106E (pt) 2009-02-10
MXPA06013064A (es) 2007-04-27
ATE412634T1 (de) 2008-11-15
US20070219209A1 (en) 2007-09-20
EA011280B1 (ru) 2009-02-27
DE602005010694D1 (de) 2008-12-11
KR20070011551A (ko) 2007-01-24
SI1751106T1 (sl) 2009-06-30
PL1751106T3 (pl) 2009-07-31
EP1751106A1 (en) 2007-02-14
EA200602080A1 (ru) 2007-04-27
DK1751106T3 (da) 2009-03-09
SK51112006A3 (sk) 2007-05-03
AU2005240842A1 (en) 2005-11-17
BG109768A (bg) 2008-03-31
JP2007537226A (ja) 2007-12-20
NZ551542A (en) 2010-06-25
IL178759A0 (en) 2007-02-11
EP1751106B1 (en) 2008-10-29
CZ2006778A3 (cs) 2007-03-07
CA2564009A1 (en) 2005-11-17
RS20060620A (en) 2008-09-29
HRP20090054T3 (en) 2009-03-31
AU2005240842B2 (en) 2011-10-06
HRP20060401A2 (en) 2007-03-31
WO2005108363A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
NO20080981L (no) Nitrocatechol-derivater som COMT-inhibitorer
NO20056130L (no) Nye substituerte 3-svovelindoler
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
NO20082136L (no) 1,5-substituerte indol-2-yl-amidderivater
NO20075406L (no) Pyrimidindionerivater som prokineticin-2-reseprorantagonister
NO20045589L (no) Nye forbindelser
NO20055219L (no) Nye forbindelser
NO20080445L (no) Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
NO20080553L (no) Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
NO20065696L (no) Piperazinderivater av alkyloksindoler som 5-HT7 reseptoraktive midler.
ATE532514T1 (de) Piperidin- und piperazinderivate
NO20065697L (no) Piperazinderivater av alkyloksindoler.
NO20082459L (no) Nye prosesser for fremstilling av piperazinyl og diazapanylbenzamidderivater
EA200602083A1 (ru) Новые пиперазиновые производные диалкилоксиндолов
NO20062700L (no) Morfolinderivater som norepinefrin reopptaksinhibitorer
HRP20060420A2 (en) Piperazine derivatives of alkyl oxindoles
ATE534638T1 (de) Piperazin-derivate
ATE468118T1 (de) Bis-1,2,3,4-tetrahydroisochinolinderivate und ihre verwendung als pharmazeutika
ATE423772T1 (de) Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
EA200602082A1 (ru) Производные индол-2-она для лечения расстройств центральной нервной системы, желудочно-кишечных расстройств и сердечно-сосудистых расстройств

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application